Membership
National
Groups
National organizations related to the goals of EURO-DURG are invited to submit a proposal for joint the EURO-DURG to the Committee. Please contact for further details with any of the following members:

Individual
Membership
In those countries in which there
is no formal National Group affiliated to EURO-DURG, Individual
Membership, and
associate membership for drug utilization researchers from outside Europe,
can be submitted to the Executive Committee. For doing that the interested
person has to submit a short Curriculum Vitae (1-2 pages, including
max. 5 recent publications/documents in the area with titles to
be given in English).
The information can be sent directly
to the secretariat:
Individual membership
is 10 ECU/year,
and this must be paid for a period of three years,
by sending a bank transfer to the EURO-DURG Account, after recieved
the acceptance from the Committee. Only after the payment of the
first three years fee (30 ECUs) the membership will be active.
EURO-DURG ACCOUNT
The VAT Number is: G38420386
and the Bank Account
is:
| EURO-DURG |
| BANK NAME: |
Bilbao-Vizcaya Bank |
| POSTAL ADDRESS: |
Weyler Square 4,
E-38004 Santa Cruz de Tenerife. Spain |
| ACCOUNT NUMBER: |
0182 - 5801 - 16 - 0011505657 |

From
the Constitution...
2. DEFINITIONS
Drug utilization and pharmaco-epidemiological research is defined as
research on the quantitative and qualitative aspects and the determinance
of drug use, the determinants and the effects on specific patients specifically
and on the population in general.
3. MISSION
The EURO DURG has as its mission "to promote drug utilization research
as a means to improved use of drugs by providing an international forum
for communication and cooperation between people interested in drug
utilization research".
To achieve its mission, the EURO DURG may:
- a) encourage communication and cooperation
between scientists in multidisciplines interested in researching drug
utilization and pharmaco-epidemiology;
b) work toward the adoption of standard international and national
drug use research methodology;
c) maximize the potential of the information available on drug utilization
for improving patient care;
d) cooperate with international and national drug regulatory authorities,
such as the World Health Organization and the European Union, European
Council, health insurance agencies, the pharmaceutical industry, academic
departments and professional bodies in furthering drug utilization
research and its application; and
e) promote the incorporation of drug utilization research and its
applications within educational programmes.
4. MEMBERSHIP
The EURO DURG accepts ordinary members, associate members and honorary
members.
- Ordinary membership
Ordinary membership of the EURO DURG is open to European residents
with an active or developing involvement in drug utilization research.
Legally constituted national organizations within Europe with a mission
in accordance with that of the EURO DURG have collective membership
of the EURO DURG.
Associated membership
EURO DURG may accept researchers with active involvement in drug
utilization research from outside Europe as associate members.
Honorary membership
EURO DURG may award the title of Honorary member to persons who
have given exceptional service to EURO DURG.


|